National Community Pharmacists Association


			Home \| Site Map \| Contact Us

Cardiovascular Care Certificate Program
– Third Edition

Please review the following information and then login to the activity.

Release Date: May 31, 2004
Expiration Date: May 31, 2007

The National Institute for Pharmacist Care Outcomes (NIPCO) is a leader in educating community pharmacists how to develop new market niches in disease management. This program will provide participants with 17 ACPE continuing education contact hours (1.7 CEUs) in pharmacy education. Upon successful completion of all modules, a Certificate of Achievement is awarded. This program can be applied toward the attainment of the Pharmacist Care Diplomate credential. For a complete listing of NIPCO-accredited certificate programs, refer to www.ncpanet.org.

Overview:

This course focuses on how pharmacists can help patients understand and manage the medications prescribed for their cardiovascular conditions specifically, hypertension, hyperlipidemia, ischemia, and congestive heart failure. Topics include: anatomy and physiology, pathophysiology, pharmacotherapy and clinical management, lifestyle issues, implementation tips, marketing strategies, illustrative documentation forms, case study applications, and extensive resource information. Pharmacists will also learn about tools to monitor, document, and bill for pharmacist care services for patients with cardiovascular disease. Also provided are a business plan and return on investment analysis worksheets.

This program can be applied toward the attainment of the NIPCO Pharmacist Care Diplomate Credential. This program will provide participants with 17 ACPE CE contact hours (1.7 CEUs) of continuing pharmaceutical education, and is available in both live and home study formats.

Professional Competencies:

Define and contrast the following cardiovascular diseases: hypertension, hyperlipidemia, congestive heart failure, and ischemic heart disease
Discuss the risk of developing these cardiovascular diseases and tools for measuring these risk factors
Describe how to establish a program in a community pharmacy to care for patients with hypertension, a lipid disorder, or other cardiovascular disease
Demonstrate how to screen for and assess patients with cardiovascular conditions using current technology and national scoring criteria
Relate the state and federal regulations pertaining to community pharmacy-based whole blood technology testing and screening procedures, e.g., OSHA, CLIA
Demonstrate how to document the essential components of a cardiovascular care plan and billing methods for pharmacist care of patients with cardiovascular conditions
Discuss national consensus guidelines, i.e., ATP III, and how they can be employed in the detection, evaluation, treatment, and monitoring of patients with hyperlipidemia
Discuss national consensus treatment guidelines and how they can be employed in the detection, treatment, and monitoring of patients with ischemia
Discuss national consensus treatment guidelines and how they can be employed in the detection, evaluation, treatment, and monitoring of patients with congestive heart failure
Discuss national consensus treatment guidelines, i.e., JNC 7, and how they can be employed in the detection, evaluation, treatment, and monitoring of patients with hypertension
Explain the importance of patient education issues related to cardiovascular disease and exercise, nutrition, and other lifestyle changes
Assess the business and economic environment with regard to establishing a Cardiovascular Care Program

Accreditation:

The National Community Pharmacists Association (NCPA) is approved by the Accreditation Council for Pharmacy Education (ACPE) as an approved provider of general pharmacy education and certificate programs. This program consists of six (6) modules and provides up to 17 contact hours (1.7 CEUs) of continuing pharmacy education credit. This program is no longer valid for credit after May 31, 2007.

Program Title	ACPE Universal Program Number
Module 1: Establishing a Niche Business in Cardiovascular Care Part A: Business Plan Development and Marketing	207-000-04-081-H01
Module 1: Establishing a Niche Business in Cardiovascular Care Part B: Documentation and Reimbursement	207-000-04-082-H01
Module 2: Pharmacist Care of Patients with Hypertension	207-000-04-083-H01
Module 3: Pharmacist Care of Patients with Dyslipidemia	207-000-04-084-H01
Module 4: Pharmacist Care of Patients with Stable Myocardial Ischemia	207-000-04-085-H01
Module 5: Pharmacist Care of Patients with Heart Failure	207-000-04-086-H01

Acknowledgements:

Advisory Panel:

Justin Boyd, Pharm.D., BCPS
Washington Regional Medical System
Springdale, Arkansas

John Delzell, M.D.
The University of Tennessee Family Medicine Center
Memphis, Tennessee

Kent Stoneking, Pharm.D.
Peoples Pharmacy
Memphis, Tennessee

Faculty:

Michael Hogue, Pharm.D.
President
Educational Innovations, Inc.
Atlanta, Georgia
and
Pharmacist, CHD Meridian Healthcare
Gadsden, Alabama

Jonathan G. Marquess, Pharm.D., CDM
Senior Partner
The Institute for Wellness and Education
Woodstock, Georgia

Kelly C. Rogers, Pharm.D.
Clinical Specialist in Cardiology
Baptist Memorial Hospital
Memphis, Tennessee

Staci-Marie Norman, Pharm.D., CDE, CDM
Consultant Pharmacist
Cardiovascular Risk Reduction
NeighborCare Pharmacy
Sound Bend, Indiana

Project Staff :

J. Chris Bradberry, Pharm.D., CDM, Project Editor
Dean
School of Pharmacy and Health Professions
Creighton University Medical Center
Omaha, Nebraska

Kathryn F. Kuhn, R.Ph., Project Director
NIPCO Executive Director
Alexandria, Virginia

Eleanor R. Nespica, Editorial Assistant
NIPCO Pharmacy Programs Coordinator
Alexandria, Virginia

Stacey Swartz, Pharm.D., Editorial Assistant
NCPA Executive Resident
Alexandria, Virginia

Geneva Briggs, Pharm.D., Medical Editor
MedOutcomes
Richmond, Virginia

Activity Fee: $175

This credentialing program is supported by an unrestricted educational grant from Pfizer. This program can be applied toward attainment of the NIPCO Pharmacist Care Diplomate credential.

NCPA Member please click here

Non-member click here

This professional education series is supported by an unrestricted educational grant from Pfizer to the National Institute for Pharmacist Care Outcomes (NIPCO), a division of the National Community Pharmacists Association (NCPA). Launched by NCPA in 1995, NIPCO is the national accrediting organization for pharmacist care education and training programs leading to the Pharmacist Care Diplomate credential and a leading authority in helping community pharmacists develop new market niches in disease management.

This education program is a publication of the National Community Pharmacists Association (NCPA). Copyright © 1998, 2004 National Community Pharmacists Association. All rights reserved. Any reproduction, photocopying, storage or transmission by magnetic or electronic means without the expressed written consent of NIPCO/NCPA and the payment of appropriate fees is strictly prohibited by law.

Home

Site Map